Vivanza Biosciences Reschedules Board Meeting for August 7 to Discuss Q1 Financial Results and Director Declarations
Vivanza Biosciences Ltd has rescheduled a meeting of its Board of Directors to address key corporate matters including the review of unaudited financial results and director declarations. The Board meeting, which was originally set for Saturday, August 01, 2026, has been moved to Friday, August 07, 2026, and will be held at the company's Registered Office.The rescheduled meeting is scheduled to consider and approve several critical items related to the company's performance and compliance status. These agenda points include reviewing the Unaudited Standalone and Consolidated Financial Results along with the Limited Review Report for the Quarter ended on June 30, 2026. The Board will also take note of the Notice of Disclosure of Interest as per Section 164 of the Companies Act, 2013, and declarations from Independent Directors under Section 149(7) of the Companies Act, 2013.
In addition to these items, the meeting is set to cover any other business with the permission of the chair.
Furthermore, management confirmed that the trading window for dealing in the securities of the company has been closed for Directors/Officers and Key Managerial Personnel and Designated Persons. This restriction remains in effect until 48 hours following the declaration of Audited Financial Results for the Quarter and Year ended June 30, 2026.
Stock Price Movement
As of 15:16, Vivanza Biosciences Ltd shares are ticking down at ₹1.84, following a 3.16% decline today. The stock experienced volatility during the trading session, moving between an intraday high of ₹1.89 and a low of ₹1.82.Disclaimer: Due care and diligence have been taken in compiling and presenting news and market-related content. However, errors or omissions may arise despite such efforts.
The information provided is for general informational purposes only and does not constitute investment advice, a recommendation, or an offer to buy or sell any securities. Readers are advised to rely on their own assessment and judgment and consult appropriate financial advisers, if required, before taking any investment-related decisions.
Any views, opinions, or statements expressed, where applicable, are those of the respective analysts or experts and do not reflect the views of this website. The website has no association with such viewpoints and does not assume any responsibility for them.